This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Aragon Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jason Michael Vaughn: Innovator in Anticancer Compositions
Introduction
Jason Michael Vaughn is a notable inventor based in High Point, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer compositions. His work focuses on innovative formulations that can aid in the treatment of various androgen receptor-related diseases, especially prostate cancer.
Latest Patents
Jason Michael Vaughn holds 1 patent for his invention titled "Anticancer compositions." This patent concerns pharmaceutical formulations of ARN-509, which can be administered to mammals, particularly humans, suffering from conditions related to androgen receptors. The invention specifically targets various forms of prostate cancer, including castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. The formulations include a solid dispersion of ARN-509 and HPMCAS, which can be obtained through methods such as melt-extrusion or spray drying.
Career Highlights
Vaughn is currently associated with Aragon Pharmaceuticals, Inc., where he continues to advance his research in cancer treatment. His innovative approach to pharmaceutical formulations has the potential to improve the efficacy of treatments for patients suffering from prostate cancer.
Collaborations
Jason Michael Vaughn has collaborated with Dennis Martin Hester, contributing to the development of groundbreaking pharmaceutical solutions.
Conclusion
Jason Michael Vaughn's work in anticancer compositions exemplifies the impact of innovation in the pharmaceutical industry. His contributions are vital in the ongoing fight against cancer, particularly prostate cancer, and highlight the importance of research and development in medical science.